Abstract A116: Mito-Met10 remodels the pancreatic tumor microenvironment through MAVS activation and CD8+ T cell metabolic reprogramming
Pancreatic ductal adenocarcinoma is characterized by an immune-excluded tumor microenvironment that limits responsiveness to immunotherapy. Because mitochondrial metabolism regulates both tumor cell survival and immune cell function, mitochondria-targeted therapies may simultaneously induce tumor cell death and r...